In today’s healthcare landscape, pharma brands face a critical challenge: how to connect meaningfully with patients and healthcare professionals in moments that truly matter. Traditional CX strategies often fall short, limited by regulatory constraints, siloed data, and static content that fails to reflect real human needs.

Havas Lynx CX is tackling this head-on with an approach that puts people at the heart of every decision. We’ve launched three innovative products designed to address the most pressing challenges: discoverability, validation and speed.

1. GEO footprint analysis: optimising for the future of search
As generative AI transforms how people seek information, traditional SEO alone no longer cuts it. Havas Lynx CX’s GEO (generative engine optimisation) footprint analysis helps pharma brands show up in AI-driven search results, where 75% of under-30s now turn for answers. By analysing local search behaviours and structuring content for visibility in generative and answer engines, this product ensures brands are discoverable when audiences need them most. Resulting in fewer barriers to access and better delivery of high-quality, human-relevant content.

2. Synthetic testing: bringing the user into every decision
User feedback is critical, but often costly and slow to acquire. Synthetic testing changes the game by creating AI-powered synthetic users, based on real HCP and patient data. These synthetic users provide fast, scalable feedback throughout strategy and asset development, enabling smarter decisions driven by human insight. Whether validating a wireframe or refining a campaign message, this tool ensures the voice of the customer is always in the room.

3. Same-day tactical ideation and prototyping: speed meets impact
In today’s ‘do more with less’ climate, speed and efficiency are essential. This product enables teams to ideate, prototype and test campaign solutions in a single day using generative AI. From interactive patient support tools to educational dashboards, it delivers high-fidelity MVPs that reduce development waste and accelerate time-to-market, without compromising quality.

Together, these innovations empower pharma to build more relevant, responsive and human-centric experiences. By combining strategic clarity with technological agility, we’re helping brands deliver real value.

Get in touch via cx@havaslynx.com

Rachael McLoughlin is Experience Director at Havas Lynx